F3. Joint ventures and associated companies
AP Accounting principles
Joint arrangements
Essity classifies its joint arrangements as joint ventures or joint operations, which are presented in Note F4 Joint operations.
Joint ventures
Joint ventures are defined as companies in which Essity together with other parties has shared control over operations. A joint venture entitles the joint owners to the net assets of the investment. Joint ventures are recognized in accordance with the equity method, meaning that a net item including the goodwill will be recognized for each joint venture in the balance sheet. A share in profits is recognized in the income statement as a component of “Share of profits of associated companies and joint ventures”. Share of profits is calculated on the basis of Essity’s share of equity in the respective joint venture. Joint arrangements recognized in accordance with the equity method are initially measured at cost. Measurement of acquired assets and liabilities is carried out in the same way as for Group companies.
Associated companies
Associated companies are companies in which the Group exercises a significant influence without the partly owned company being a Group company or a joint arrangement. Normally, this means that the Group owns between 20% and 50% of the votes. Accounting for associated companies is carried out according to the equity method and they are initially measured at cost. Valuation of acquired assets and liabilities is performed in the same manner as for Group companies and the carrying amount for associated companies includes any goodwill and other Group adjustments.
The Group’s share of profit after tax arising in the associate after the acquisition is recognized in the consolidated income statement in the line “Share of profits of associated companies and joint ventures”. Share of profits is calculated on the basis of Essity’s share of equity in the respective associate.
SEKm |
2020 |
2019 |
2018 |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Joint ventures |
|
|
|
|||||||
Value, January 1 |
181 |
171 |
144 |
|||||||
Net increase in joint ventures1) |
17 |
8 |
19 |
|||||||
Translation differences |
–9 |
2 |
8 |
|||||||
Value, December 31 |
189 |
181 |
171 |
|||||||
|
|
|
|
|||||||
Associated companies |
|
|
|
|||||||
Value, January 1 |
684 |
606 |
918 |
|||||||
Company acquisitions |
– |
3 |
– |
|||||||
Company divestments |
– |
– |
–3 |
|||||||
Net change in associated companies1) |
1 |
43 |
–21 |
|||||||
Impairment of associated companies |
– |
– |
–278 |
|||||||
Reclassification between associated companies and Group companies |
– |
– |
–6 |
|||||||
Translation differences |
–27 |
32 |
–4 |
|||||||
Value, December 31 |
658 |
684 |
606 |
|||||||
BS TF3:1 Value, December 31, joint ventures and associated companies |
847 |
865 |
777 |
|||||||
|
Joint ventures and associated companies
Asaleo Care
Asaleo Care Ltd (Asaleo Care) manufactures and markets Consumer Tissue, Professional Hygiene and Personal Care products. Essity has licensed its Tork and TENA brands to Asaleo Care for sale in Australia, New Zealand and Fiji. Essity’s share of Asaleo Care amounts to 36%. In 2018, the company recognized an impairment loss of AUD 148.5m relating to assets in the Tissue business in Australia and the Personal Care business in New Zealand. During 2019, the company divested Consumer Tissue operations in Australia. In 2020, the company discontinued the Baby Care operations in New Zealand. Essity has recognized the effects of these transactions as items affecting comparability, see Note B3.
Bunzl & Biach
Bunzl & Biach GmbH (Bunzl & Biach) Vienna, is Essity’s single largest joint venture that operates in the recovered paper market and supplies raw materials to Essity’s business.
|
Joint ventures |
|
Associated companies |
|
|
|
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Bunzl & Biach |
|
Asaleo Care Ltd |
|
Total |
|||||||||||||||||||||
SEKm |
2020 |
2019 |
2018 |
|
2020 |
20191) |
2018 |
|
2020 |
2019 |
2018 |
|||||||||||||||
Condensed income statement |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Net sales |
1,134 |
1,424 |
1,471 |
|
2,655 |
2,795 |
2,645 |
|
3,789 |
4,219 |
4,116 |
|||||||||||||||
Depreciation/amortization |
–14 |
–13 |
–13 |
|
–171 |
–168 |
–169 |
|
–185 |
–181 |
–182 |
|||||||||||||||
Operating profit |
34 |
30 |
47 |
|
390 |
346 |
126 |
|
424 |
376 |
173 |
|||||||||||||||
Interest income |
– |
– |
– |
|
1 |
3 |
3 |
|
1 |
3 |
3 |
|||||||||||||||
Interest expenses |
– |
– |
– |
|
–52 |
–80 |
–98 |
|
–52 |
–80 |
–98 |
|||||||||||||||
Other financial items |
– |
– |
1 |
|
–1 |
–4 |
–3 |
|
–1 |
–4 |
–2 |
|||||||||||||||
Tax expense |
–7 |
–9 |
–14 |
|
–97 |
–73 |
–23 |
|
–104 |
–82 |
–37 |
|||||||||||||||
Profit for the period, continuing operations |
27 |
21 |
34 |
|
241 |
192 |
5 |
|
268 |
213 |
39 |
|||||||||||||||
Profit/loss for the period, discontinued operations |
– |
– |
– |
|
–37 |
–9 |
–710 |
|
–37 |
–9 |
–710 |
|||||||||||||||
Profit/loss for the period |
27 |
21 |
34 |
|
204 |
183 |
–705 |
|
231 |
204 |
–671 |
|||||||||||||||
Other comprehensive income for the period |
– |
– |
– |
|
–44 |
–13 |
63 |
|
–44 |
–13 |
63 |
|||||||||||||||
Comprehensive income for the period |
27 |
21 |
34 |
|
160 |
170 |
–642 |
|
187 |
191 |
–608 |
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Condensed balance sheet |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Non-current assets |
160 |
163 |
147 |
|
1,929 |
2,041 |
1,728 |
|
2,089 |
2,204 |
1,875 |
|||||||||||||||
Cash and cash equivalents |
64 |
31 |
12 |
|
345 |
216 |
426 |
|
409 |
247 |
438 |
|||||||||||||||
Other current assets |
174 |
167 |
238 |
|
690 |
969 |
885 |
|
864 |
1,136 |
1,123 |
|||||||||||||||
Assets held for sale |
– |
– |
– |
|
– |
– |
1,131 |
|
– |
– |
1,131 |
|||||||||||||||
Total assets |
398 |
361 |
397 |
|
2,964 |
3,226 |
4,170 |
|
3,362 |
3,587 |
4,567 |
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Non-current financial liabilities |
90 |
69 |
118 |
|
932 |
1,114 |
2,061 |
|
1,022 |
1,183 |
2,179 |
|||||||||||||||
Other non-current liabilities |
63 |
69 |
67 |
|
206 |
363 |
131 |
|
269 |
432 |
198 |
|||||||||||||||
Current financial liabilities |
– |
– |
– |
|
48 |
9 |
4 |
|
48 |
9 |
4 |
|||||||||||||||
Other current liabilities |
26 |
31 |
34 |
|
544 |
513 |
639 |
|
570 |
544 |
673 |
|||||||||||||||
Liabilities directly linked to assets held for sale |
– |
– |
– |
|
– |
– |
294 |
|
– |
– |
294 |
|||||||||||||||
Total liabilities |
179 |
169 |
219 |
|
1,730 |
1,999 |
3,129 |
|
1,909 |
2,168 |
3,348 |
|||||||||||||||
Net assets |
219 |
192 |
178 |
|
1,234 |
1,227 |
1,041 |
|
1,453 |
1,419 |
1,219 |
|||||||||||||||
Group share of net assets |
107 |
94 |
87 |
|
446 |
444 |
376 |
|
553 |
538 |
463 |
|||||||||||||||
Surplus value |
69 |
74 |
71 |
|
174 |
191 |
187 |
|
243 |
265 |
258 |
|||||||||||||||
Carrying amount of the companies |
176 |
168 |
158 |
|
620 |
635 |
563 |
|
796 |
803 |
721 |
|||||||||||||||
Carrying amount of other joint ventures |
13 |
13 |
13 |
|
– |
– |
– |
|
13 |
13 |
13 |
|||||||||||||||
Carrying amount of other associated companies |
– |
– |
– |
|
38 |
49 |
43 |
|
38 |
49 |
43 |
|||||||||||||||
BS TF3:2 Carrying amount of joint ventures and associated companies |
189 |
181 |
171 |
|
658 |
684 |
606 |
|
847 |
865 |
777 |
|||||||||||||||
Market value, December 31 |
|
|
|
|
4,690 |
3,745 |
3,144 |
|
|
|
|
|||||||||||||||
|
Company name |
Corp. Reg. No. |
Domicile |
Share of |
Share of |
Share of |
Carrying |
Carrying |
Carrying |
---|---|---|---|---|---|---|---|---|
Joint ventures |
|
|
|
|
|
|
|
|
Bunzl & Biach GmbH |
FN79555v |
Vienna, Austria |
49 |
49 |
49 |
176 |
168 |
158 |
Other |
|
|
|
|
|
13 |
13 |
13 |
|
|
|
|
|
|
|
|
|
Associated companies |
|
|
|
|
|
|
|
|
Asaleo Care Ltd |
61 154 461 300 |
Melbourne, Australia |
36 |
36 |
36 |
620 |
635 |
563 |
Other |
|
|
|
|
|
38 |
49 |
43 |
BS TF3:1 Carrying amount, December 31 |
|
|
|
847 |
865 |
777 |